title: [Intravesical ionophoresis of medicines (an experimental study)].
abstract: The depth of drug penetration into the wall of the urinary bladder in intravesical ionophoresis (IVIP), IVIP influence on functional condition of the lower urinary tracts were studied on 15 female dogs. Functional condition of the lower urinary tracts was characterized by pressure in the urinary bladder, "volume-pressure" index, bioelectric activity of the urethra. The pressure was registered by electromanometry. Bioelectric activity of the urethra was studied with electromyography and tetrapolar rheography. The above indices were registered synchroneously on a multichannel recorder. Intraoperative cystomanometry was made in 7 tyopental narcotized animals. Samples of blood and vesicular tissue were taken for immunofluorescent study before and after IVIP. Medicines were accumulated best in mucous and submucous layers (0.039 +/- 0.0012 and 0.0338 +/- 0.0050 mcm/mg tissue, respectively). After IVIP intravesical pressure was, on the average, lower in the same filling volumes as before IVIP. A mean amplitude of spontaneous fluctuations of pressure in the urinary bladder in its filling after IVIP was also lower than the baseline. After IVIP, pressure in the urinary bladder in voiding was much lower than before the procedure, maximal capacity of the urinary bladder and elasticity of the wall increased. Bioelectrical activity of the urethral wall was registered in the same mean pressure and capacity as before IVIP. Intensity of micturition after IVIP course decreased both at rest and in diuretic load with lasix. Time to micturition was increased with an increase in the number of procedures of IVIP. Thus, the experimental study showed pathogenetic validity of intravesical ionophoresis of medicines in the treatment of chronic recurrent cystitis.
authors.forename: D Iu
authors.initials: DIu
authors.lastname: Pushkar'
authors.forename: I L
authors.initials: IL
authors.lastname: Korsunskaia
authors.forename: K P
authors.initials: KP
authors.lastname: Tevlin
mesh_terms: D000283:Administration, Intravesical; D000818:Animals; D003556:Cystitis / Q000188:drug therapy; D004121:Dimethyl Sulfoxide / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics; D004285:Dogs; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics; D006854:Hydrocortisone / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics; D007478:Iontophoresis / Q000379:methods*; D008012:Lidocaine / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics; D023421:Models, Animal; D004364:Pharmaceutical Preparations / Q000008:administration & dosage* / Q000097:blood; D001743:Urinary Bladder / Q000187:drug effects* / Q000378:metabolism
chemical_list: D004364:Pharmaceutical Preparations; D006493:Heparin; D008012:Lidocaine; D006854:Hydrocortisone; D004121:Dimethyl Sulfoxide